Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60

被引:84
|
作者
Quintana, FJ [1 ]
Carmi, P [1 ]
Mor, F [1 ]
Cohen, IR [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 169卷 / 06期
关键词
D O I
10.4049/jimmunol.169.6.3422
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adjuvant arthritis (AA) is an autoimmune disease inducible in rats involving T cell reactivity to the mycobacterial 65-kDa heat shock protein (HSP65). HSP65-specific T cells cross-reactive with the mammalian 60-kDa heat shock protein (HSP60) are thought to participate in the modulation of AA. In this work we studied the effects on AA of DNA vaccination using constructs coding for HSP65 (pHSP65) or human HSP60 (pHSP60). We found that both constructs could inhibit AA, but that pHSP60 was more effective than pHSP65. The immune effects associated with specific DNA-induced suppression of AA were complex and included enhanced T cell proliferation to a variety of disease-associated Ags. Effective vaccination with HSP60 or HSP65 DNA led paradoxically to up-regulation of IFN-gamma secretion to HSP60 and, concomitantly, to down-regulation of IFN-gamma secretion to the P180-188 epitope of HSP65. There were also variable changes in the profiles of IL-10 secretion to different Ags. However, vaccination with pHSP60 or pHSP65 enhanced the production of TGFbeta1 to both HSP60 and HSP65 epitopes. Our results support a regulatory role for HSP60 autoreactivity in AA and demonstrate that this control mechanism can be activated by DNA vaccination with both HSP60 or HSP65.
引用
收藏
页码:3422 / 3428
页数:7
相关论文
共 50 条
  • [31] Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis
    Prakken, ABJ
    vanEden, W
    Rijkers, GT
    Kuis, W
    Toebes, EA
    DeGraeffMeeder, ER
    vanderZee, R
    Zegers, BJM
    ARTHRITIS AND RHEUMATISM, 1996, 39 (11): : 1826 - 1832
  • [32] INHIBITION OF ADJUVANT ARTHRITIS BY SOME PROTEIN ANTIGENS
    PEARSON, CM
    WOOD, FD
    ARTHRITIS AND RHEUMATISM, 1964, 7 (03): : 337 - &
  • [33] Heat shock protein HSP60 and the perspective for future using as vaccine antigens
    Bajzert, Joanna
    Stefaniak, Tadeusz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 1149 - 1168
  • [34] Antibodies to chlamydial heat shock protein 60 is associated with coronary artery disease but antibodies to human heat shock protein 60 and Escherichia coli homologs are not
    Mahdi, OSM
    Horne, BD
    Muellen, K
    Muhlestein, JB
    Byrne, GI
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 277A - 277A
  • [35] Inhibitor of heat-shock protein 90 enhances the antitumor effect of DNA vaccine targeting clients of heat-shock protein
    Lin, Chi-Chen
    Tu, Cheng-Fen
    Yen, Meng-Chi
    Chen, Ming-Chuan
    Hsieh, Wan-Jung
    Chang, Wen-Chang
    Chang, Wen-Tsang
    Lai, Ming-Derg
    MOLECULAR THERAPY, 2007, 15 (02) : 404 - 410
  • [36] Human heat shock protein 60 but not 90 is a a T cell antigen
    Rahman, Mizanur
    Steuer, Johnny
    Gillgren, Peter
    Liu, Anquan
    Hayderi, Assim
    Frostegard, Johan
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 305 - 305
  • [37] Heat Shock Protein 27 and 60 Directly Activate Human Microglia
    Pan, Li
    Cho, Kin-Sang
    Do, Chi-Wai
    Chen, Dongfeng
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [38] Recognition of human heat shock protein 60 by human naive T lymphocytes.
    Ramage, JM
    Goodall, JC
    Young, JL
    Gaston, JSH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 37 - 37
  • [39] Growth inhibition of Helicobacter pylori by monoclonal antibody to heat-shock protein 60
    Yamaguchi, H
    Osaki, T
    Taguchi, H
    Hanawa, T
    Yamamoto, T
    Fukuda, M
    Kawakami, H
    Hirano, H
    Kamiya, S
    MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (12) : 909 - 916
  • [40] Heat shock protein 70 and antibodies to heat shock protein 60 are associated with cerebrovascular atherosclerosis
    Galovic, Ruzica
    Flegar-Mestric, Zlata
    Vidjak, Vinko
    Matokanovic, Mirela
    Barisic, Karmela
    CLINICAL BIOCHEMISTRY, 2016, 49 (1-2) : 66 - 69